Log In
Print
BCIQ
Print
Print this Print this
 

VC-01

  Manage Alerts
Collapse Summary General Information
Company ViaCyte Inc.
DescriptionViaCyte's PEC-01 cells, which are human embryonic stem cells (hESCs)-derived pancreatic progenitor cells, encapsulated in ViaCyte's implantable Encaptra delivery system
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today